Who owns PROCESSA PHARMACEUTICALS INC?
- Ticker: PCSA
- CUSIP Number: 74275c403
Tip: Access positions for across all investors
Analyze quarterly positions in Processa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Processa Pharmaceuticals stock
Who bought or sold PROCESSA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Connective Capital Management | 85k | $164k | 21% | Jun 2026 |
|
| Stonepine Capital Management | 55k | $106k | 0% | Jun 2026 |
|
| Geode Capital Management | 22k | $42k | -11% | Jun 2026 |
|
| Citadel Advisors | 21k | $41k | 100% | Jun 2026 |
|
| XTX Topco | 13k | $26k | 100% | Jun 2026 |
|
| Jane Street | 13k | $26k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 13k | $24k | 0% | Jun 2026 |
|
| Intl Fcstone | 11k | $30k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 11k | $21k | 0% | Jun 2026 |
|
| UBS Group | 7.8k | $15k | 208% | Jun 2026 |
|
| Tower Research Capital | 2.5k | $4.8k | 172% | Jun 2026 |
|
| Citigroup | 14.00 | $35.000000 | 100% | Mar 2026 |
|
| Jones Financial Companies, L.L | 7.00 | $12.999700 | 0% | Jun 2026 |
|